跳至主要内容
临床试验/ACTRN12606000139572
ACTRN12606000139572已完成不适用

A pilot study to validate the use of high flow humidified oxygen therapy in a Cardiothoracic and Vascular Intensive Care Unit (CVICU), in patients requiring supplemental oxygen to treat hypoxia as assessed by arterial blood gas (PaO2).

Fisher and Paykel Healthcare0 个研究点目标入组 60 人开始时间: 2006年4月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • Consent has been obtained or is likely to be obtained- Patient currently on oxygen therapy via nasal prongs or mask- In the opinion of the treating clinical team the patient has sub optimal gas exchange and/or the patient is in a degree of mild respiratory distress.

排除标准

  • The patient is likely to require imminent intubation (within 30mins)- The patient has a tracheostomy in situ- Patient would not be offered mechanical/non invasive ventilation due to clinical condition/prognosis- The patient has previously been enrolled in this study- The patient has already been treated with high flow nasal oxygen in the CVICU or Ward 42 this admission- Contraindication to high flow nasal oxygen.

研究者

发起方
Fisher and Paykel Healthcare

相似试验